Objectives: Topical minoxidil and oral finasteride are the gold standard therapies for AGA and the only two drugs currently that have US Food and Drug Administration (FDA)-approved indications for the treatment of hair loss.
Introduction: Emerging treatment modalities for hair loss include injectable platelet rich plasma (PRP), low-level laser therapy (LLLT), microneedling and oral nutraceuticals. Several peer reviewed studies have demonstrated the safety and efficacy of these methodologies although no standardized protocols exist to date. A new trend of combining therapies in order to achieve maximum
Materials / method: Peer-reviewed studies were analyzed for new treatment modalities showing a safe efficacious profile for treating hair loss.
Results: Several new treatment therapies including lasers, PRP and topical/oral cosmeceuticals are showing promising results in treating hair loss in both men and women. Combination approaches using PRP with fractional lasers and/or microneedling can increase the efficacy of these new treatment modalities.
Conclusion: New generation of treatment modalities show promise as therapeutic options for hair loss.
利益冲突声明
您有否接受任何资金来支持研究这个主题？
否
您是否接受过关于这项研究的任何酬金或其他报酬？
是
请注明名称（个人，公司，学会等等）: Cutera venus
你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否
你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。
